Glucotrack, Inc. Announces Reverse Stock Split

1-for-15 reverse stock split to become effective as of the opening of trading on August 31, 2026

Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a healthcare technology and biopharmaceutical company operating Lōkahi Therapeutics™, today announced that it will effect a 1-for-15 reverse stock split (the “Reverse Stock Split”) of its issued and outstanding common stock par value $0.001 per share (the “Common Stock”), effective with the opening of trading on Monday, August 31, 2026.